Starting in 2027, private health plans must cover at least one insulin product in each type with no deductible. The most a patient would pay is $35 per month (or 25% of the plan's negotiated price, whichever is less). These copays count toward the annual out-of-pocket maximum.
Pick the stance you'd want ModernAction to turn into a message to your elected officials about this issue.
Start with your overall view on the topic. If that first answer could map differently across the linked bills, we'll show the provisions that matter before that message gets written.
Start with the main topic. If nuance changes what your stance means across the linked bills, review the provisions before that stance is turned into a message for your elected officials.
Starting in 2027, private health plans must cover at least one insulin product in each type with no deductible. The most a patient would pay is $35 per month (or 25% of the plan's negotiated price, whichever is less). These copays count toward the annual out-of-pocket maximum.
What's your stance?
